Navigation Links
Pharmacyclics Reports First Quarter 2013 Results
Date:5/1/2013

132012AssetsCash, cash equivalents and marketable securities 1

$
511,247$
317,114Other current assets 2

21,41629,378Total current assets

532,663346,492Property and equipment, net

9,4786,403Other assets

3,0202,234Total assets

$
545,161$
355,129Liabilities and Stockholders' EquityDeferred revenue - current portion

$
8,036$
8,139Other current liabilities

39,35321,118Total current liabilities

47,38929,257Deferred revenue - non-current portion

59,87962,562Deferred rent

783784Total liabilities

108,05192,603Stockholders' equity

437,110262,526Total liabilities and stockholders' equity

$
545,161$
355,1291 Marketable securities

$
8,721$
9,6812 As of March 31, 2013 and December 31, 2012, Other current assets includes $17.1 million and $26.6 million, respectively, due to the Company from Janssen under the collaboration and license agreement.

Pharmacyclics, Inc.Condensed Consolidated Statements of Operations
(unaudited; in thousands, except per share data)

Three Months EndedMar. 31,Mar. 31,20132012Revenue:  License and milestone revenue

$
-$
-  Collaboration services revenue

2,8461,927Total revenue

2,8461,927Operating expenses*:  Research and Development

35,78415,828  General and Administrative

20,0264,061Total operating expenses

55,81019,889Loss from operations

(52,964)(17,962)Interest and other income, net

7956Loss before income taxes

(52,885)(17,906)Income tax benefit

9745,083Net loss

$
(51,911)$
(12,823)Net loss per share:Basic

$
(0.73)$
(0.19)Diluted

$

'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
2. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
3. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
4. Pharmacyclics, Inc. Prices Public Offering of Common Stock
5. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
6. Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
7. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
8. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
9. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
10. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
11. Hospira Reports First-Quarter 2013 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
(Date:1/14/2014)... Mass. , Jan. 14, 2014 HeartWare ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced that it expects revenues for the fourth ... expected full-year 2013 revenues to approximately $208 million. ...
(Date:1/14/2014)... HAMILTON, N.J. , Jan. 14, 2014 InformEx, ... buyers and sellers of high-value chemistry, will hold the 30 ... Miami Beach Convention Center from January 21-24. ... than 3,500 attendees from top pharmaceutical, fine chemical and specialty ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
(Date:4/17/2014)... One of the most popular vaccine brands for ... doctors may be overlooking some cost factors when choosing ... more expensive option, according to a new study by ... to administer can be driven by numerous factors," says ... a professor of computer science and of mathematics at ...
(Date:4/17/2014)... published in the April issue of Immunity , ... for Medical Research, says it,s time to take a ... treating sepsis, which kills millions worldwide every year, ... molecules released into the bloodstream to fight an injury ... necessary for maintaining good health without inflammation, wounds ...
(Date:4/17/2014)... estimated that as many as 10 million older Americans ... loneliness and isolation. , However, new research a ... older Americans for six years found that Internet ... depression by more than 30 percent. , "That,s a ... University professor of telecommunication, information studies and media who ...
(Date:4/17/2014)... YORK April 17, 2014 EcoHealth Alliance, a ... health issues, published a comprehensive review today examining the ... Marburg virus. The review calls for improved global surveillance ... as the recent outbreak of Ebola in West Africa ... the countries of Guinea and Liberia. According to ...
(Date:4/17/2014)... a colored ribbon representing a disease. A pink ribbon is ... does one think of with lung cancer?, Although white has ... the disease, black may be the only one they think ... patients, primarily smokers between the ages of 51 to 79 ... felt by these patients, the emotional toll it can have ...
Breaking Medicine News(10 mins):Health News:Study recalculates costs of combination vaccines 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Internet use can help ward off depression among elderly 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Unraveling the 'black ribbon' around lung cancer 2
... successfully isolated nanoparticles from human kidney stones in cell ... to be associated with nanoparticles. ,The findings, ... of Investigative Medicine, are significant because it is one ... are viable living forms that can lead to disease ...
... Research Service (ARS) scientists have reported that the newly ... to produce flour with 25% more magnesium than commercial ... of the ARS Soft Wheat Quality Research Unit at ... M. Peterson at the University of Idaho Research and ...
... shock and disappointment on hearing the news about a ... five Bulgarian nurses and one Palestinian doctor for supposedly ... ,George Bush has expressed his "disappointment" to Georgi Parvanov, ... to strive for the release of the five nurses ...
... Basic Health Needs – a Report. A newspaper on Sunday ... 1999 in the nation's largest county jail system came after ... volume of inmates, coupled with a shortage of doctors and ... waiting to be examined. ,An investigation by the ...
... scientists have identified a cell population that is a ... frontotemporal dementia//, which is as common as Alzheimer's disease ... ,Because the cells arose only recently in evolutionary ... and humans-- and are particularly abundant in humans, and ...
... California, San Diego biologists have shown that the chemical ... //of electrical activity in the developing nervous system. The ... potential as a treatment for a wide range of ... in the early on-line edition of the journal Proceedings ...
Cached Medicine News:Health News:Link Between Nanoparticles and Kidney Stones 2Health News:Link Between Nanoparticles and Kidney Stones 3Health News:Health Care Suffers at Los Angeles Jails: Report 2Health News:Study Offers Window into Human Behavior, Brain Disease 2Health News:Study Offers Window into Human Behavior, Brain Disease 3Health News:Study Offers Window into Human Behavior, Brain Disease 4Health News:Electrical Activity Alters Language Used By Nerve Cells 2Health News:Electrical Activity Alters Language Used By Nerve Cells 3
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
The Bair Hugger outpatient blanket makes it easy to give your patients the benefit of prewarming and enhance patient comfort during outpatient procedures....
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
The full body blanket provides coverage to the entire patient....
Medicine Products: